We are live on ! Find out more
SBWIC

Schaper Benz & Wise Investment Counsel Portfolio holdings

AUM $1.5B
1-Year Est. Return 31.02%
This Fund
S&P 500
This Quarter Est. Return
+3.6%
1 Year Est. Return
+31.02%
3 Year Est. Return
+83.38%
5 Year Est. Return
+96.2%
10 Year Est. Return
+357.25%
AUM
$792M
AUM Growth
+$22M
Cap. Flow
-$498K
Cap. Flow %
-0.06%
Top 10 Hldgs %
28.24%
Holding
108
New
1
Increased
40
Reduced
50
Closed
2

Top Buys

Rank Stock Value
1
AMCR icon
Amcor
AMCR
+$5.46M
2
REGN icon
Regeneron Pharmaceuticals
REGN
+$673K
3
WBA
Walgreens Boots Alliance
WBA
+$672K
4
XLNX
Xilinx Inc
XLNX
+$475K
5
NATI
National Instruments Corp
NATI
+$427K

Top Sells

Rank Stock Value
1
BMS
Bemis
BMS
+$5.36M
2
WU icon
Western Union
WU
+$909K
3
LIN icon
Linde
LIN
+$426K
4
ADBE icon
Adobe
ADBE
+$309K
5
PG icon
Procter & Gamble
PG
+$288K

Sector Composition

Rank Sector Weight
1 Technology 24.4%
2 Healthcare 18.22%
3 Financials 16.62%
4 Communication Services 9.57%
5 Consumer Staples 6.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VAR
26
DELISTED
Varian Medical Systems, Inc.
VAR
$13.1M 1.65%
96,206
-918
-0.9% -$123K
WFC icon
27
Wells Fargo
WFC
$265B
$13M 1.64%
273,917
+3,121
+1% +$146K
SBUX icon
28
Starbucks
SBUX
$121B
$12.5M 1.58%
149,611
-1,749
-1% -$137K
MDT icon
29
Medtronic
MDT
$115B
$12.4M 1.57%
127,277
+1,433
+1% +$131K
LIN icon
30
Linde
LIN
$227B
$12.4M 1.56%
61,695
-2,275
-4% -$426K
XLNX
31
DELISTED
Xilinx Inc
XLNX
$12.3M 1.55%
104,171
+4,075
+4% +$475K
NATI
32
DELISTED
National Instruments Corp
NATI
$11.1M 1.4%
263,246
+10,005
+4% +$427K
V icon
33
Visa
V
$680B
$10.8M 1.37%
62,466
+147
+0.2% +$24.1K
SSNC icon
34
SS&C Technologies
SSNC
$18.7B
$10.3M 1.3%
178,406
+3,500
+2% +$211K
AME icon
35
Ametek
AME
$58.7B
$9.8M 1.24%
107,910
-100
-0.1% -$8.57K
NKE icon
36
Nike
NKE
$61.1B
$9.74M 1.23%
116,034
+880
+0.8% +$74.1K
ADI icon
37
Analog Devices
ADI
$190B
$9.45M 1.19%
83,756
+1,673
+2% +$181K
ECL icon
38
Ecolab
ECL
$79.8B
$9.27M 1.17%
46,969
-330
-0.7% -$61.4K
PFE icon
39
Pfizer
PFE
$152B
$9.19M 1.16%
223,530
-1,312
-0.6% -$52.1K
GOOGL icon
40
Alphabet (Google) Class A
GOOGL
$4.3T
$9.09M 1.15%
167,960
-740
-0.4% -$42.8K
BEN icon
41
Franklin Resources
BEN
$17B
$9.05M 1.14%
260,132
-3,795
-1% -$129K
INTU icon
42
Intuit
INTU
$91.5B
$8.57M 1.08%
32,781
+243
+0.7% +$61.8K
TFC icon
43
Truist Financial
TFC
$63.6B
$7.89M 1%
160,600
+160
+0.1% +$7.84K
MSFT icon
44
Microsoft
MSFT
$3.74T
$7M 0.88%
52,219
-230
-0.4% -$29.2K
WRI
45
DELISTED
Weingarten Realty Investors
WRI
$6.9M 0.87%
251,720
-2,060
-0.8% -$59.3K
IBM icon
46
IBM
IBM
$226B
$6.73M 0.85%
51,046
-1,124
-2% -$148K
META icon
47
Meta Platforms (Facebook)
META
$1.55T
$6.42M 0.81%
33,277
+2,287
+7% +$418K
REGN icon
48
Regeneron Pharmaceuticals
REGN
$83B
$5.9M 0.75%
18,848
+2,022
+12% +$673K
ENB icon
49
Enbridge
ENB
$113B
$5.85M 0.74%
162,173
+26
+0% +$947
AMCR icon
50
Amcor
AMCR
$21.7B
$5.65M 0.71%
+98,361
New +$5.46M
1
2
3 4 5

Similar funds

SGM
Seven Grand Managers Bronxville, New York $1.5B AUM 57.16% 1-Year Est. Return
CPA
Capital Performance Advisors Walnut Creek, California $1.5B AUM 21.4% 1-Year Est. Return
NSGL
No Street GP LP San Francisco, California $1.5B AUM 34.53% 1-Year Est. Return
MCM
Maple Capital Management Montpelier, Vermont $1.49B AUM 23.46% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
AAM
Aureus Asset Management Boston, Massachusetts $1.5B AUM 20.3% 1-Year Est. Return
CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return
RIM
Rush Island Management New York $1.49B AUM 4.65% 1-Year Est. Return

Schaper Benz & Wise Investment Counsel's Q2 2019 Portfolio in Review

As of Q2 2019, Schaper Benz & Wise Investment Counsel held 108 positions worth $792M, up 2.9% from $770M the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Trading was light in Q2 2019: portfolio turnover was 2.8%. Schaper Benz & Wise Investment Counsel opened 1 new position and exited 2, leaving the 108-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 25% a quarter earlier, followed by Healthcare and Financials.

  • Schaper Benz & Wise Investment Counsel's largest Q2 2019 buy was Amcor: 98,361 shares worth $5.65M.
  • Schaper Benz & Wise Investment Counsel added most to Regeneron Pharmaceuticals in Q2 2019, an estimated $673K increase.
  • Schaper Benz & Wise Investment Counsel's biggest Q2 2019 reduction was Linde, cutting an estimated $426K.
  • Schaper Benz & Wise Investment Counsel fully exited Bemis in Q2 2019, selling an estimated $5.36M.
  • Schaper Benz & Wise Investment Counsel's ten largest holdings make up 28% of its $792M portfolio in Q2 2019.
  • Schaper Benz & Wise Investment Counsel opened 1 new position and closed 2 in Q2 2019.
  • Schaper Benz & Wise Investment Counsel's portfolio value rose 2.9% quarter-over-quarter to $792M.

Based on Schaper Benz & Wise Investment Counsel's 13F filing for Q2 2019, filed 5 Aug 2019.